Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

Currently, Alzheimer’s affects over 55 million people globally, and cases are projected to triple by 2050. Advances in ...

Alzheimer's is generally characterised by memory loss and other cognitive abilities serious enough to interfere with daily ...

Semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

Most people associate memory loss with Alzheimer's. But research suggests it may not be the first sign - a systematic review ...

"Paul and I have been through a great deal together," said Colleen Kelly Mellor, the author of a new book called "Az and Me: ...

As the number of people living with dementia in the UK is set to rise to 1.4 million by 2040, BBC Morning Live star Dr Xand ...

This health journey for Hemsworth began while he was filming Limitless, a documentary series where he discovered he carries ...

Staying active, eating healthier and considering medication can help manage hypertension and reduce dementia risk ...

The investigational anti-tau antibody bepranemab missed its primary cognitive endpoint in a phase II trial of prodromal to ...

Diadem presents new findings on early Alzheimer’s disease detection using p53-specific antibody at CTAD 2024: Milano, Italy Tuesday, November 5, 2024, 18:00 Hrs [IST] Diadem SpA ...